Gene therapies continue to advance in AMD

WAILEA, Hawaii — Gene therapy is a rapidly advancing innovation in the world of retinal diseases, according to a speaker at Retina 2024.
Allen C. Ho, MD, said gene therapies have already taken hold across medicine, with about 20 therapies obtaining FDA approval.
“Gene therapy is happening now, and it’s something to pay attention to,” he said. “I’m not naive or biased enough to think that this is going to replace our therapies or injections.”
The group of approved treatments includes therapies such as Luxturna (voretigene neparvovec, Spark Therapeutics)

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart